The Challenge:
Applications of effective treatments for devastating diseases affecting skeletal or muscle tissues have been limited by the lack of tissue-specific delivery .
The Goal:
Tissue-targeted or enriched delivery of novel therapeutics can significantly improve therapeutic potential and safety of our molecules.
The Solution:
We are searching for innovative strategies to deliver biologics, small molecules, nucleotide-based drugs or genomic medicines specifically to skeletal or muscle tissues.
